Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper

Despite interesting and unique pharmacological properties, levosimendan has not proven a clear superiority to placebo in the patient populations that have been enrolled in the various recent multicenter randomized controlled trials. However, the pharmacodynamic effects of levosimendan are still cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholley, Bernard, Levy, Bruno, Fellahi, Jean-Luc, Longrois, Dan, Amour, Julien, Ouattara, Alexandre, Mebazaa, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883606/
https://www.ncbi.nlm.nih.gov/pubmed/31783891
http://dx.doi.org/10.1186/s13054-019-2674-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883606/
https://www.ncbi.nlm.nih.gov/pubmed/31783891
http://dx.doi.org/10.1186/s13054-019-2674-4

Ejemplares similares